276 related articles for article (PubMed ID: 15247916)
1. A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes.
Guo D; Li M; Zhang Y; Yang P; Eckenrode S; Hopkins D; Zheng W; Purohit S; Podolsky RH; Muir A; Wang J; Dong Z; Brusko T; Atkinson M; Pozzilli P; Zeidler A; Raffel LJ; Jacob CO; Park Y; Serrano-Rios M; Larrad MT; Zhang Z; Garchon HJ; Bach JF; Rotter JI; She JX; Wang CY
Nat Genet; 2004 Aug; 36(8):837-41. PubMed ID: 15247916
[TBL] [Abstract][Full Text] [Related]
2. Association of SUMO4 M55V polymorphism with autoimmune diabetes in Latvian patients.
Sedimbi SK; Shastry A; Park Y; Rumba I; Sanjeevi CB
Ann N Y Acad Sci; 2006 Oct; 1079():273-7. PubMed ID: 17130565
[TBL] [Abstract][Full Text] [Related]
3. Functional evaluation of the type 1 diabetes (T1D) susceptibility candidate genes.
Park Y
Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S110-5. PubMed ID: 17448564
[TBL] [Abstract][Full Text] [Related]
4. The type 1 diabetes susceptibility gene SUMO4 at IDDM5 is not associated with susceptibility to rheumatoid arthritis or juvenile idiopathic arthritis.
Gibbons LJ; Thomson W; Zeggini E; Worthington J; Barton A; Eyre S; Donn R; Hinks A
Rheumatology (Oxford); 2005 Nov; 44(11):1390-3. PubMed ID: 16159953
[TBL] [Abstract][Full Text] [Related]
5. No association of the codon 55 methionine to valine polymorphism in the SUMO4 gene with Graves' disease.
Jennings CE; Owen CJ; Wilson V; Pearce SH
Clin Endocrinol (Oxf); 2005 Mar; 62(3):362-5. PubMed ID: 15730420
[TBL] [Abstract][Full Text] [Related]
6. SUMO4 M55V polymorphism affects susceptibility to type I diabetes in HLA DR3- and DR4-positive Swedish patients.
Sedimbi SK; Luo XR; Sanjeevi CB; ; ; Lernmark A; Landin-Olsson M; Arnqvist H; Björck E; Nyström L; Ohlson LO; Scherstén B; Ostman J; Aili M; Bååth LE; Carlsson E; Edenwall H; Forsander G; Granström BW; Gustavsson I; Hanås R; Hellenberg L; Hellgren H; Holmberg E; Hörnell H; Ivarsson SA; Johansson C; Jonsell G; Kockum K; Lindblad B; Lindh A; Ludvigsson J; Myrdal U; Neiderud J; Segnestam K; Sjöblad S; Skogsberg L; Strömberg L; Ståhle U; Thalme B; Tullus K; Tuvemo T; Wallensteen M; Westphal O; Dahlquist G; Aman J
Genes Immun; 2007 Sep; 8(6):518-21. PubMed ID: 17554341
[TBL] [Abstract][Full Text] [Related]
7. Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes.
Park Y; Park S; Kang J; Yang S; Kim D
Nat Genet; 2005 Feb; 37(2):112; author reply 112-3. PubMed ID: 15678137
[No Abstract] [Full Text] [Related]
8. SUMO4 M55V variant is associated with diabetic nephropathy in type 2 diabetes.
Lin HY; Wang CL; Hsiao PJ; Lu YC; Chen SY; Lin KD; Hsin SC; Hsieh MC; Shin SJ
Diabetes; 2007 Apr; 56(4):1177-80. PubMed ID: 17229939
[TBL] [Abstract][Full Text] [Related]
9. No association of the SUMO4 polymorphism M55V variant in type 2 diabetes in Iranian subjects.
Fallah S; Jafarzadeh M; Hedayati M
Diabetes Res Clin Pract; 2010 Nov; 90(2):191-5. PubMed ID: 20728233
[TBL] [Abstract][Full Text] [Related]
10. Functional variants in SUMO4, TAB2, and NFkappaB and the risk of type 1 diabetes.
Kosoy R; Concannon P
Genes Immun; 2005 May; 6(3):231-5. PubMed ID: 15729364
[TBL] [Abstract][Full Text] [Related]
11. A M55V polymorphism in the SUMO4 gene is associated with a reduced prevalence of diabetic retinopathy in patients with Type 1 diabetes.
Rudofsky G; Schlotterer A; Humpert PM; Tafel J; Morcos M; Nawroth PP; Bierhaus A; Hamann A
Exp Clin Endocrinol Diabetes; 2008 Jan; 116(1):14-7. PubMed ID: 17926234
[TBL] [Abstract][Full Text] [Related]
12. SLC22A4, RUNX1, and SUMO4 polymorphisms are not associated with rheumatoid arthritis: a case-control study in a Spanish population.
Orozco G; Sánchez E; González-Gay MA; López-Nevot MA; Torres B; Pascual-Salcedo D; Balsa A; Pablos JL; García A; González-Escribano MF; Martín J
J Rheumatol; 2006 Jul; 33(7):1235-9. PubMed ID: 16821265
[TBL] [Abstract][Full Text] [Related]
13. Association of small ubiquitin-like modifier 4 (SUMO4) variant, located in IDDM5 locus, with type 2 diabetes in the Japanese population.
Noso S; Fujisawa T; Kawabata Y; Asano K; Hiromine Y; Fukai A; Ogihara T; Ikegami H
J Clin Endocrinol Metab; 2007 Jun; 92(6):2358-62. PubMed ID: 17374705
[TBL] [Abstract][Full Text] [Related]
14. Association of SUMO4 M55V and -94ins/del gene variants with type-2 diabetes.
Sozen S; Horozoglu C; Bireller ES; Karaali Z; Cakmakoglu B
In Vivo; 2014; 28(5):919-23. PubMed ID: 25189908
[TBL] [Abstract][Full Text] [Related]
15. Association of SUMO4 M55V polymorphism with type 1 diabetes in Chinese children.
Sang Y; Zong W; Liu M; Yan J
J Pediatr Endocrinol Metab; 2010 Oct; 23(10):1083-6. PubMed ID: 21158221
[TBL] [Abstract][Full Text] [Related]
16. No evidence of association of CTLA-4 -318 C/T, 159 C/T, 3' STR and SUMO4 163 AG polymorphism with autoimmune diabetes.
Caputo M; Cerrone GE; Mazza C; Cédola N; Targovnik HM; Gustavo DF
Immunol Invest; 2007; 36(3):259-70. PubMed ID: 17558709
[TBL] [Abstract][Full Text] [Related]
17. Evidence for the role of small ubiquitin-like modifier 4 as a general autoimmunity locus in the Japanese population.
Tsurumaru M; Kawasaki E; Ida H; Migita K; Moriuchi A; Fukushima K; Fukushima T; Abiru N; Yamasaki H; Noso S; Ikegami H; Awata T; Sasaki H; Eguchi K
J Clin Endocrinol Metab; 2006 Aug; 91(8):3138-43. PubMed ID: 16735488
[TBL] [Abstract][Full Text] [Related]
18. SUMO4 gene polymorphisms in Chinese Han patients with Behcet's disease.
Hou S; Yang P; Du L; Zhou H; Lin X; Liu X; Kijlstra A
Clin Immunol; 2008 Oct; 129(1):170-5. PubMed ID: 18657476
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the regulatory roles of the SUMO.
Hwang KW; Won TJ; Kim H; Chun HJ; Chun T; Park Y
Diabetes Metab Res Rev; 2011 Nov; 27(8):854-61. PubMed ID: 22069273
[TBL] [Abstract][Full Text] [Related]
20. SUMO4 and its role in type 1 diabetes pathogenesis.
Wang CY; She JX
Diabetes Metab Res Rev; 2008 Feb; 24(2):93-102. PubMed ID: 17990297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
